For a science company, the website is the first document diligence reads.
We build digital experiences worthy of the science behind them.
We build digital experiences worthy of the science behind them.
What we do
A website is the first thing an investor studies, the first impression a clinician or partner forms, and the primary interface between your work and the world.
We design and build digital products and experiences that serve science-driven organizations from first website to post-IPO rebuild, and well beyond the website, into portals, data interfaces, congress technology, and formats that do not have templates yet. Every interface does deliberate work, not decorative work. That discipline matters more in science than almost anywhere, because the audiences are unforgiving and the subject is hard.
Services
Websites for science organizations at every growth stage, from a startup’s first public presence to the inflection point just before enterprise scale. We understand the distinct communication demands at each stage and design accordingly, and we are direct about where another partner may serve a full-enterprise infrastructure better.
Designed environments for organizing and surfacing complex scientific, clinical, or programmatic information, for internal teams, partner networks, or the public. Disease-education portals, clinical evidence libraries, program knowledge hubs. As much information architecture as visual design.
Interfaces that communicate data outputs, research findings, and program metrics to specialist and non-specialist audiences at once. Dashboards and interactive displays that make complexity legible without flattening it, especially for global health programs, research consortia, and data-driven platforms.
Touch interactives, kiosks, and large-format digital exhibits for congresses and permanent installations, built to work in high-traffic, high-noise environments where you have seconds to earn attention and a narrow window to communicate something genuinely complex.
The formats that do not have established templates: immersive science environments, AI-assisted knowledge tools, spatial and sensor-driven experiences. Plus the strategy that precedes a build, audience mapping, information architecture, and content strategy for teams that need to think carefully before they build.
Who this is for
Biotech and pharma companies
Preparing for a financing event, a launch, or a rebrand.
Global health organizations and foundations
Communicating program impact and mobilizing partners and funders.
Discovery-stage and platform startups
Establishing a first professional presence.
Organizations with complex science
Reaching audiences who each relate to that science differently.
The moments we're built for
A founding, when the first site establishes credibility fast.
A fundraise, when the site is read as a diligence document.
A growth stage, when expanding pipelines and audiences outpace the current build.
A public health crisis or education push, when a portal or dashboard is how the public gets the truth.
Selected work
Telios Pharma
An interactive congress environment and iPad experience at the center of an award-winning debut.
Kartos and Telios
A multi-surface digital exhibit built to reach clinicians, investors, and patients at once.
TriSalus Life Sciences
A full corporate site refresh alongside its science library.
Related capabilities
Common questions
Corporate websites, knowledge portals, data and research portals, congress and exhibit interactive technology, and novel interfaces that do not have a template yet.
Our in-house UX and development team, with our Boston-based engineering partner, CoreSecure, on Veeva-compliant medical information hubs and large CMS builds. You always know which of us is doing what.
We design for science organizations from a first website to a post-IPO rebuild, and we will say plainly when a full-enterprise infrastructure is better served by another partner.
Yes, and we prefer to. Audience mapping, information architecture, and content strategy, so the build answers a question instead of restating your org chart.
Start a project conversation.